CVS Health replaces CEO as it faces a range of challenges

Taking stock of the drug industry, from the lab to the medicine chest

October 18, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Carolyn Kaster/AP STAT+ | CVS Health replaces CEO as it faces a range of challenges The company's stock has tumbled this year as its PBM, insurance, and pharmacy arms all face challenges. By Andrew Joseph and Tara Bannow STAT+ | Sales from controversial drug discount program rose to $63 billion last year The sales amount to a 23.4% increase from the previous year, according to the Health Resources & Service Administration, which oversees the program. By Ed Silverman STAT+ | Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings The coalition said the deal could reduce access to GLP-1s, and harm competition in development of cell and gene therapies. By Ed Silverman Photo illustration:STAT; Photo: Genentech STAT+ | Opinion: Genentech executive Fritz Bittenbender: Beware political soundbites Political rhetoric around health care costs consistently gets us nowhere, writes Genentech executive Fritz Bittenbender. By Fritz Bittenbender STAT+ | Amgen, Biogen and Takeda talk about R&D on tough targets At the STAT summit, executives discuss their challenges, and hopeful signals, about breaking into markets on obesity and Alzheimer's. By Elizabeth Cooney STAT+ | How a drug discount program intended to benefit the poor got entangled in a California rent-control fight A California ballot measure could provide something of a roadmap to the drug industry as it seeks new ways to curb 340B discounts. By John Wilkerson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser